TrialHaematologica2021

Lenalidomide before and after autologous stem cell transplantation for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial.

Graham H Jackson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.